BRST5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 363: | Line 363: | ||
| | | | ||
|- | |- | ||
|[[BRST5:Adenoid cystic carcinoma|Adenoid cystic carcinoma]]||Disease||Katherine Geiersbach | |[[BRST5:Adenoid cystic carcinoma|Adenoid cystic carcinoma]]||Disease||Katherine Geiersbach; | ||
Jun Liao | |||
|10/12/02022 | |10/12/02022 | ||
|11/11/2023 | |11/11/2023 | ||
| Line 372: | Line 373: | ||
|2024 template added | |2024 template added | ||
|- | |- | ||
|[[BRST5:Secretory carcinoma|Secretory carcinoma]]||Disease||Hui Chen | |[[BRST5:Secretory carcinoma|Secretory carcinoma]]||Disease||Hui Chen; | ||
Katherine Geiersbach | |||
|10/12/2022 | |10/12/2022 | ||
|11/11/2023 | |11/11/2023 | ||
| Line 476: | Line 478: | ||
| | | | ||
|- | |- | ||
|[[BRST5:Phyllodes tumour|Phyllodes tumour]]||Disease||Emilie Lalonde | |[[BRST5:Phyllodes tumour|Phyllodes tumour]]||Disease||Emilie Lalonde; | ||
H. Evin Gulbahce; | |||
Katherine Geiersbach | |||
|8/11/2023 | |8/11/2023 | ||
|11/11/2023 | |11/11/2023 | ||
| Line 759: | Line 764: | ||
---- | ---- | ||
|- | |- | ||
|[[BRST5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]||Disease|| | |[[BRST5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | ||
| | | | ||
| | | | ||
| Line 768: | Line 773: | ||
| | | | ||
|- | |- | ||
|[[BRST5:Follicular lymphoma|Follicular lymphoma]]||Disease|| | |[[BRST5:Follicular lymphoma|Follicular lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | ||
| | | | ||
| | | | ||
| Line 788: | Line 793: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
|[[BRST5:Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma]]||Disease|| | |[[BRST5:Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | ||
| | | | ||
| | | | ||
| Line 797: | Line 802: | ||
| | | | ||
|- | |- | ||
|[[BRST5:Burkitt lymphoma|Burkitt lymphoma]]||Disease|| | |[[BRST5:Burkitt lymphoma|Burkitt lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | ||
| | | | ||
| | | | ||